BRS5(FM3) - Gut-Vagal Neuromodulation & ENS Signalling
(Gut-to-Brain Nerve Pathways)
Primary Mechanisms
- BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation
- BRS5-FM3-PM8 — Neurotransmitter Precursor Biotransformation & Availability
Key Constraints
1. Definition
A diet-actionable control point regulating vagal and enteric nervous system signalling through microbial activity, barrier state, and metabolite or neurochemical cues (gut-to-brain neuromodulation).
- Modulates vagal and enteric nervous system signalling through gut-derived cues.
- Influences neurotransmitter precursor biotransformation and availability — Supporting BRS1.
- Links gut ecology and barrier state to autonomic neuromodulation — Supporting BRS6.
2. Primary Biological Effects
↑ vagal signalling; ↑ ENS-brain communication; ↑ mood/attentional regulation support
4. Mechanistic Basis (Integrated FM Narrative)
4.1 Functional Rationale
Gut-side neural signalling and precursor handling provide complementary routes by which intestinal conditions can influence wider regulation, without relocating central neurotransmitter synthesis to the gut.
4.2 Evidence Summary
A defined Lactobacillus exposure altered central GABA-receptor expression through the vagus in mice. Reviews establish vagal communication, while tryptophan-metabolism work shows gut-side processing and fibre-dependent microbial interactions. Neural communication and precursor conversion are different evidence routes. [1, 2, 8, 9]
Effective communication and precursor handling would support gut–brain regulatory context. These findings do not establish transfer of microbial GABA into the brain or a shared human functional outcome from combining these routes.
4.3 Suboptimal Function & Its Effects
Gut-vagal neuromodulation & ens signalling may weaken when fermentable fibre availability declines or when low fibre and low plant-diversity dietary patterns.
Low fibre and low plant-diversity dietary patterns may reduce BRS5(KC1) — Fermentable Fibre Availability. Ultra-processed diets displacing fermentable whole-food substrates may further strain pool availability, repeated low-intake of resistant starch and soluble fibre classes, erratic meal patterns reducing consistent microbial substrate delivery, while inflammatory or metabolic burden increasing ecological instability.
These pressures may impair BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation, weaken BRS5-FM3-PM8 — Neurotransmitter Precursor Biotransformation & Availability, and reduce the effectiveness of BRS5-FM1-PM3 — Microbial Barrier–Immune Interface Support. At the FM level, this may shift BRS5(FM3) toward reduced gut-vagal neuromodulation & ens signalling performance.
5. Connected Mechanisms
- BRS1-FM3-PM7 - Neuronal Membrane DHA Incorporation — biological connection relevant to this mechanism
- BRS6-FM1-PM2 - Glycaemic Variability Regulation — biological connection relevant to this mechanism
7. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Synthesis: Vagal–ENS signalling modulation supports autonomic recovery pathways that help maintain stress resilience when gut–brain communication remains intact. Human vagal and probiotic–stress literature provides convergent low–medium framing without equating to vagal stimulation or probiotic treatment claims.
- Key References:
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Synthesis: Integrated vagal–enteric signalling helps shape autonomic and gut–brain tone relevant to emotional regulation under daily stress load. Early human and translational evidence supports low–medium biological relevance; ADHD-specific emotional-outcome trials on this FM remain limited.
- Key References:
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low
- Synthesis: Neurotransmitter-precursor biotransformation and ENS signalling together influence precursor and signalling availability that can support attention stability via gut–brain routes. Human microbiome–ADHD associations support biological plausibility, while Evidence Confidence stays lower because bridging to attention outcomes remains incomplete on this integrated FM.
- Key References:
8. References
- [1] Bravo et al. (2011) — Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression
- [2] Austelle et al. (2022) — A Comprehensive Review of Vagus Nerve Stimulation for Depression
- [3] Johnstone et al. (2021) — Anxiolytic Effects of a Galacto-oligosaccharides Prebiotic in Healthy Females (18–25 Years) with
- [4] Wang et al. (2022) — Effect of Bifidobacterium Bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity
- [5] Pärtty et al. (2015) — A Randomized Trial
- [6] Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
- [7] Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- [8] O'Mahony et al. (2015) — Serotonin, Tryptophan Metabolism and the Brain-gut-microbiome Axis
- [9] Sinha et al. (2024) — Dietary Fibre Directs Microbial Tryptophan Metabolism via Metabolic Interactions in the Gut